- Home
- PODD vs LII Comparison
PODD vs LII Comparison
Compare PODD & LII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PODD
- LII
- Stock Information
- Founded
- PODD 2000
- LII 1895
- Country
- PODD United States
- LII United States
- Employees
- PODD N/A
- LII N/A
- Industry
- PODD Medical/Dental Instruments
- LII Industrial Machinery/Components
- Sector
- PODD Health Care
- LII Industrials
- Exchange
- PODD Nasdaq
- LII Nasdaq
- Market Cap
- PODD 22.1B
- LII 17.4B
- IPO Year
- PODD 2007
- LII 1999
- Fundamental
- Price
- PODD $321.76
- LII $484.47
- Analyst Decision
- PODD Strong Buy
- LII Hold
- Analyst Count
- PODD 19
- LII 11
- Target Price
- PODD $346.95
- LII $607.00
- AVG Volume (30 Days)
- PODD 536.4K
- LII 552.5K
- Earning Date
- PODD 11-06-2025
- LII 10-22-2025
- Dividend Yield
- PODD N/A
- LII 1.06%
- EPS Growth
- PODD N/A
- LII 12.46
- EPS
- PODD 3.45
- LII 23.67
- Revenue
- PODD $2,521,800,000.00
- LII $5,345,300,000.00
- Revenue This Year
- PODD $29.32
- LII N/A
- Revenue Next Year
- PODD $18.37
- LII $7.61
- P/E Ratio
- PODD $93.51
- LII $20.68
- Revenue Growth
- PODD 27.11
- LII 3.77
- 52 Week Low
- PODD $230.05
- LII $479.40
- 52 Week High
- PODD $353.50
- LII $689.44
- Technical
- Relative Strength Index (RSI)
- PODD 52.32
- LII 38.67
- Support Level
- PODD $290.16
- LII $481.07
- Resistance Level
- PODD $335.00
- LII $495.09
- Average True Range (ATR)
- PODD 10.92
- LII 19.44
- MACD
- PODD 0.27
- LII 0.11
- Stochastic Oscillator
- PODD 71.75
- LII 10.88
About PODD Insulet Corporation
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.
About LII Lennox International Inc.
Lennox International manufactures and distributes heating, ventilating, air conditioning, and refrigeration products to replacement (75% of sales) and new construction (25% of sales) markets. In fiscal 2024, residential HVAC was 67% of sales and commercial HVAC and Heatcraft refrigeration was 33% of sales. The company goes to market with multiple brands, but Lennox is the company's flagship HVAC brand. The Texas-based company is focused on North America after the sale of its European HVAC and refrigeration businesses in late 2023.